During the past decade, URO Ltd. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "URO Ltd." #1 collaborator was "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "URO Ltd." are "Cancer" (1 trials), "Overactive Bladder" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "URO Ltd." in a lesser frequency.

Most popular intervention types in "URO Ltd." are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darolutamide (Nubeqa, BAY1841788)" (2 trials), "Androgen deprivation therapy (ADT)" (1 trials), "Placebo" (1 trials), "Tolterodine Tartrate ER" (1 trials) and "Tolterodine placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "URO Ltd." are 2 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "URO Ltd.". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in URO Ltd., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in URO Ltd., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".